970x125
Acheson, L. S., Williams, B. H., Farrell, M., McKetin, R., Ezard, N., & Siefried, K. J. (2023). Pharmacological treatment for methamphetamine withdrawal: A systematic review and meta‐analysis of randomised controlled trials. Drug and Alcohol Review, 42(1), 7-19.
Brecht, M. L., & Herbeck, D. (2014). Time to relapse following treatment for methamphetamine use: a long-term perspective on patterns and predictors. Drug and alcohol dependence, 139, 18-25.
Brown, H. D., & DeFulio, A. (2020). Contingency management for the treatment of methamphetamine use disorder: A systematic review. Drug and Alcohol Dependence, 216, 108307.
Cumming, C., Troeung, L., Young, J. T., Kelty, E., & Preen, D. B. (2016). Barriers to accessing methamphetamine treatment: a systematic review and meta-analysis. Drug and alcohol dependence, 168, 263-273.
Jones, C. M., Houry, D., Han, B., Baldwin, G., Vivolo‐Kantor, A., & Compton, W. M. (2022). Methamphetamine use in the United States: epidemiological update and implications for prevention, treatment, and harm reduction. Annals of the New York Academy of Sciences, 1508(1), 3-22.
Li, M. J., Chau, B., Belin, T., Carmody, T., Jha, M. K., Marino, E. N., & Shoptaw, S. J. (2024). Extended observation of reduced methamphetamine use with combined naltrexone plus bupropion in the ADAPT‐2 trial. Addiction, 119(10), 1840-1845.
Mu, L. L., Wang, Y., Wang, L. J., Xia, L. L., Zhao, W., Song, P. P., … & Jiao, D. L. (2022). Associations of executive function and age of first use of methamphetamine with methamphetamine relapse. Frontiers in Psychiatry, 13, 971825.
